MSDS   | : | D-Gluconic acid, compd. with
N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-
tetraazatetradecane diimidamide (2:1)
| CAS   | : | 18472-51-0 | SYNONYMS   | : | * Abacil
* Arlacide G
* Bacticlens
* Biguanide, 1,1'-hexamethylenebis(5-(p-chlorophenyl)-, digluconate
* 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane digluconate
* Caswell No. 481G
* Chlorhexidine digluconate
* Chlorhexidine di-D-gluconate
* Chlorhexidine gluconate
* Chlorhexidin glukonatu
* Corsodyl
* Disteryl
* Gluconic acid, compd. with 1,1'-hexamethylene
bis(5-(p-chlorophenyl)biguanide) (2:1), D-
* 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)digluconate
* Hibiclens
* Hibidil
* Hibiscrub
* Hibitane 5
* Orahexal
* Peridex
* Peridex (antiseptic)
* Plac out
* Plurexid
* Septeal
* Unisept
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : DU1950000
CHEMICAL NAME : D-Gluconic acid, compd. with
N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-
tetraazatetradecane diimidamide (2:1)
CAS REGISTRY NUMBER : 18472-51-0
OTHER CAS REGISTRY NOS. : 14007-07-9
60042-57-1
LAST UPDATED : 199706
DATA ITEMS CITED : 10
MOLECULAR FORMULA : C22-H30-Cl2-N10.2C6-H12-O7
MOLECULAR WEIGHT : 897.88
WISWESSER LINE NOTATION : GR DMYUM&MYUM&M6MYUM&MYUM&MR DG &QVYQYQYQYQ1Q 2
COMPOUND DESCRIPTOR : Drug
Mutagen
SYNONYMS/TRADE NAMES :
* Abacil
* Arlacide G
* Bacticlens
* Biguanide, 1,1'-hexamethylenebis(5-(p-chlorophenyl)-, digluconate
* 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane digluconate
* Caswell No. 481G
* Chlorhexidine digluconate
* Chlorhexidine di-D-gluconate
* Chlorhexidine gluconate
* Chlorhexidin glukonatu
* Corsodyl
* Disteryl
* Gluconic acid, compd. with 1,1'-hexamethylene
bis(5-(p-chlorophenyl)biguanide) (2:1), D-
* 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)digluconate
* Hibiclens
* Hibidil
* Hibiscrub
* Hibitane 5
* Orahexal
* Peridex
* Peridex (antiseptic)
* Plac out
* Plurexid
* Septeal
* Unisept
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3320 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 24200 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1260 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1140 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 12900 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,255,1982
** MUTATION DATA **
TYPE OF TEST : DNA repair
TEST SYSTEM : Bacteria - Bacillus subtilis
DOSE/DURATION : 1 mg/L
REFERENCE :
ESKGA2 Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15
Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953-
Volume(issue)/page/year: 32,171,1986
*** U.S. STANDARDS AND REGULATIONS ***
EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
FEREAC Federal Register. (U.S. Government Printing Office, Supt. of
Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year:
54,7740,1989
*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***
NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X3093
No. of Facilities: 4592 (estimated)
No. of Industries: 5
No. of Occupations: 36
No. of Employees: 643404 (estimated)
No. of Female Employees: 561783 (estimated)
*** STATUS IN U.S. ***
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-(2-(dimethylamino)ethyl)-, alpha-D-
| 67441-19-4 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-(3-(dimethylamino)propyl)-, alpha-D-
| 53914-14-0 |
2(3H)-Furanone, 5-(1,2-heptadiene-4,6-diynyl)dihydro-
| 502-12-5 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-(2-(dipropylamino)ethyl)-, alpha-D-
| 67441-20-7 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-ethyl-, alpha-D-
| 22331-28-8 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-methyl-, alpha-D-
| 43138-64-3 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-(2-(morpholino)ethyl)-, alpha-D-
| 67441-23-0 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-pentyl-, alpha-D-
| 67441-25-2 |
Glucofuranose, 1,25,6-di-O-isopropylidene-O-phenylthiocarbonate, alpha-D-
| 19189-62-9 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-propargyl-, alpha-D-
| 67441-18-3 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-propyl-, alpha-D-
| 71978-76-2 |
Glucofuranose,1:2,5:6-di-O-isopropylidene-3-O-(2-(pyrrolidinyl)ethyl)-, alpha-D-
| 56824-23-8 |
Glucofuranose,1,2-O-isopropylidene-3,5,6-tri-O-methylsulfonyl-, D-
| 39686-83-4 |
2(3H)-Furanone, 5-hexyldihydro-
| 706-14-9 |
alpha-D-Glucofuranose, 1,2-O-(1-methylethylidene)-,tributanoate
| 125161-49-1 |
Glucofuranoside, ethyl-3,5,6-tri-o-benzyl-, D-
| 10310-32-4 |
Glucofuranuronic acid,1,2-O-(2,2,2-trichloroethylidene)-, lactone
| 10310-32-4 |
D-glycero-D-Gluco-heptonic acid, tin salt
| 10310-32-4 |
D-Gluco-D-mannan
| 11078-31-2 |
Gluconamide, N-(2-mercaptoethyl)-
| 3786-84-3 |
D-Gluconamide,N,N'-(2,4,6-triiodo-5-((methylamino)carbonyl)-1,3-phenylene)bis-
| 63941-74-2 |
Gluconic acid
| 133-42-6 |
Gluconic acid, D-
| 526-95-4 |
D-Gluconic acid, compd. withN,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecane diimidamide (2:1)
| 18472-51-0 |
2(5H)-Furanone,5-(4-hydroxy-2-butenylidene)-3-(3-hydroxypropenyl)-
| 26047-03-0 |
Gluconic acid, copper(2+) salt (21) D-
| 527-09-3 |
D-Gluconic acid,2-((4-(dimethylamino)phenyl)methyl)hydrazide
| 527-09-3 |
Gluconic acid, D-, compd. with2-(diphenylmethylene)butylamine (1:1)
| 28599-37-3 |
Gluconic acid, D-, compd. with hydroquinidine (11)
| 21666-86-4 |
Gluconic acid, iron(2+) salt (21)
| 299-29-6 |
Gluconic acid, iron(II) salt, hydrate (212)
| 22830-45-1 |
Gluconic acid, delta-lactone, D-
| 90-80-2 |
Gluconic acid, compd. with6-(methylamino)-4,4-diphenyl-3-heptanol acetate(ester) (1:1)
| 7645-01-4 |
D-Gluconic acid, 2-(1-methyl-2-phenylethyl)hydrazide
| 7645-01-4 |
D-Gluconic acid, compd. withN-(1-methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine
| 21156-48-9 |
|
|